Results 151 to 160 of about 60,678 (260)

Cell‐Type‐Resolved Proteomics Reveals Distinct Immune and Metabolic Programs Between Primary and Recurrent Ascites in HGSOC

open access: yesPROTEOMICS – Clinical Applications, Volume 20, Issue 5, September 2026.
ABSTRACT High‐grade serous ovarian carcinoma (HGSOC) frequently recurs after platinum–taxane therapy, yet recurrence‐associated changes within ascites remain unclear. We performed cell‐type‐resolved quantitative proteomics on paired ascites samples collected at primary diagnosis and at disease recurrence from three HGSOC patients, profiling unsorted ...
Bo Ren   +6 more
wiley   +1 more source

How I Treat: Immune dysregulation in Down syndrome. [PDF]

open access: yesJ Hum Immun
Gans M   +4 more
europepmc   +1 more source

Primary Peritoneal Perivesical Hemangiosarcoma in 16 Dogs (2020–2024)

open access: yesVeterinary Medicine and Science, Volume 12, Issue 5, September 2026.
Primary peritoneal perivesical hemangiosarcoma in dogs may represent a distinct anatomical presentation of visceral hemangiosarcoma. Despite a high metastatic rate and guarded prognosis, multimodal treatment combining surgery and chemotherapy significantly improved progression‐free and disease‐specific survival compared with chemotherapy alone ...
Jose Roca   +3 more
wiley   +1 more source

Syndromic Convergence in Aquaculture Disease Management: A Critical Review of Climate‐Pathobiome Interactions, Diagnostic Frameworks, and Knowledge Gaps

open access: yesReviews in Aquaculture, Volume 18, Issue 4, September 2026.
Syndromic convergence (SyCo) reframes aquaculture disease as the synergistic product of climate‐driven stressors, pathobiome communities, and host immune compromise, not single pathogens. A five‐criterion scoring matrix, composite early warning index, and three‐layer intervention framework together operationalize this shift toward predictive ...
Ilhan Altinok
wiley   +1 more source

SCID newborn screening: seven-year performance and outcomes including T-cell lymphopenia in Catalonia (Spain). [PDF]

open access: yesFront Immunol
Argudo-Ramírez A   +15 more
europepmc   +1 more source

Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 3, Page 485-498, September 2026.
ABSTRACT This retrospective analysis evaluated 12 dogs with hepatocellular carcinoma (HCC) who received stereotactic body radiation therapy (SBRT). Dogs received between 6 and 25 Grey (Gy) per fraction for 1–5 fractions for a total dose of 13–30 Gy. Eleven patients (92%) experienced acute adverse effects (AE), with the majority being VRTOG grade 2–3 ...
Victoria Lee Newberry   +3 more
wiley   +1 more source

Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic

open access: yesFrontiers in Oncology, 2020
Giuseppe Carlo Iorio   +2 more
doaj   +1 more source

Investigators' response. [PDF]

open access: yesClin Transl Radiat Oncol
Corbeau A   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy